Overview

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two anti-HIV drugs, FTC and lamivudine (3TC), when given with either stavudine (d4T) or zidovudine (ZDV) and one other anti-HIV drug.
Phase:
Phase 3
Details
Lead Sponsor:
Triangle Pharmaceuticals
Treatments:
Emtricitabine
HIV Protease Inhibitors
Lamivudine
Protease Inhibitors
Reverse Transcriptase Inhibitors
Stavudine
Zidovudine